Macrophage Inflammatory Protein 3α Is Expressed at Inflamed Epithelial Surfaces and Is the Most Potent Chemokine Known in Attracting Langerhans Cell Precursors

This publication has 77 references indexed in Scilit:

• Transforming Growth Factor β1, in the Presence of Granulocyte/Macrophage Colony-stimulating Factor and Interleukin 4, Induces Differentiation of Human Peripheral Blood Monocytes into Dendritic Langerhans Cells
  The Journal of Experimental Medicine, 1998
• CCR6, a CC Chemokine Receptor that Interacts with Macrophage Inflammatory Protein 3α and Is Highly Expressed in Human Dendritic Cells
  The Journal of Experimental Medicine, 1997
• The Enigmatic Plasmacytoid T Cells Develop into Dendritic Cells with Interleukin (IL)-3 and CD40-Ligand
  The Journal of Experimental Medicine, 1997
• Genetic defect in T lymphocyte‐specific homing into peripheral lymph nodes
  European Journal of Immunology, 1997
• A Role for Endogenous Transforming Growth Factor β1 in Langerhans Cell Biology: The Skin of Transforming Growth Factor β1 Null Mice Is Devoid of Epidermal Langerhans Cells
  The Journal of Experimental Medicine, 1996
• Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
  Nature Medicine, 1996
• New insights into the mobilization and phagocytic activity of dendritic cells.
  The Journal of Experimental Medicine, 1996
• Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
  The Journal of Experimental Medicine, 1994
• CD4 antibody treatment of severe psoriasis
  The Lancet, 1991
• The Dendritic Cell System and its Role in Immunogenicity
  Annual Review of Immunology, 1991